Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/07/2012 | US20120141987 Method and probes for the detection of cancer |
06/07/2012 | US20120141982 Culture Method for Obtaining a Clonal Population of Antigen-Specific B Cells |
06/07/2012 | US20120141981 Second harmonic imaging nanoprobes and techniques for use thereof |
06/07/2012 | US20120141980 Method for isolating viruses |
06/07/2012 | US20120141628 Method for the prevention or reduction of haze in beverages |
06/07/2012 | US20120141604 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers |
06/07/2012 | US20120141522 Recombinant protective protein from streptococcus pneumoniae |
06/07/2012 | US20120141519 Reagents and methods for detecting influenza virus proteins |
06/07/2012 | US20120141518 Human Parvovirus: Bocavirus |
06/07/2012 | US20120141517 Novel immunotherapy against several tumors including neuronal and brain tumors |
06/07/2012 | US20120141506 Treatment of non-proliferative cystic disease |
06/07/2012 | US20120141505 Cd19-ligand and use |
06/07/2012 | US20120141501 Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component |
06/07/2012 | US20120141498 Use of pkc isozymes for diagnosis and treatment of neuroblastoma |
06/07/2012 | US20120141496 Iap bir domain binding compounds |
06/07/2012 | US20120141495 Method for suppressing tumor growth by blocking fibroblast growth factor receptor, and method for diagnosing malignant neoplasms |
06/07/2012 | US20120141493 Human binding molecules having killing activity against staphylococci and uses thereof |
06/07/2012 | US20120141491 Methods and compositions for the treatment of cancers and pathogenic infections |
06/07/2012 | US20120141490 Antibodies That Bind Selectively To P25 And Uses Therefor |
06/07/2012 | US20120141488 Novel g protein coupled receptor protein and use thereof |
06/07/2012 | US20120141487 Moraxella catarrhalis antigens |
06/07/2012 | US20120141482 Molecular complexes which modify immune responses |
06/07/2012 | US20120141477 Antibodies That Specifically Bind to ABeta Oligomers and Uses Thereof |
06/07/2012 | US20120141462 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
06/07/2012 | US20120141457 Lateral Flow Immunoassay for Complement Activation and Methods of Use for Point-of-Care Assessment of Complement-Associated Disorders |
06/07/2012 | US20120141434 Methods for Selecting Expanded Stem Cell Populations |
06/07/2012 | US20120141431 Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreas |
06/07/2012 | US20120141376 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
06/07/2012 | US20120141375 Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer |
06/07/2012 | US20120141374 Methods and compositions for targeting hepsin |
06/07/2012 | US20120141373 Antibodies and Methods of Use Thereof |
06/07/2012 | US20120141371 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
06/07/2012 | US20120141329 Microfluidic apparatus with integrated porous-substrate/sensor for real-time (bio) chemical molecule detection |
06/07/2012 | US20120140205 Methods and systems for controlling the flow of particles for detection |
06/07/2012 | US20120138485 Organelle bioelectrodes and methods of making and using the same |
06/07/2012 | US20120138484 Analyte Sensors Comprising Thickeners, Enzyme Stabilizers and Osmium Boronates |
06/07/2012 | US20120138469 Microfluidic devices for transverse electrophoresis and isoelectric focusing |
06/07/2012 | US20120138465 Electro-blotting devices, systems, and kits and methods for their use |
06/07/2012 | US20120137758 Animal urinary function measuring device and animal urinary function measuring method |
06/07/2012 | CA2824724A1 Methods and systems for spatially identifying abnormal cells |
06/07/2012 | CA2821515A1 Anti-ngf compositions and use thereof |
06/07/2012 | CA2821067A1 Neoantibodies for diagnosing tissue injury |
06/07/2012 | CA2819538A1 Method for prognosticating the clinical response of a patient to b-lymphocyte inhibiting or depleting therapy in interferon driven diseases such as sle. |
06/07/2012 | CA2819463A1 Tomm34 peptides and vaccines including the same |
06/07/2012 | CA2819356A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
06/07/2012 | CA2819345A1 Methods to assess treatment outcomes in reward deficiency syndrome (rds) behaviors utilizing expression profiling |
06/07/2012 | CA2819303A1 A composition for detecting biofilms on viable tissues |
06/07/2012 | CA2819237A1 Protein renaturation microfluidic devices and methods of making and using the same |
06/07/2012 | CA2819187A1 Covalently dimerized bivalent binding agents |
06/07/2012 | CA2819181A1 Methods and systems for analyzing images of specimens processed by a programmable quantitative assay |
06/07/2012 | CA2819126A1 Sample metering device and assay device with integrated sample dilution |
06/07/2012 | CA2818495A1 Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
06/07/2012 | CA2818428A1 Assays and biomarkers for lrrk2 |
06/07/2012 | CA2818171A1 Phagocytic activity as a marker of synucleinopathic disease |
06/07/2012 | CA2818010A1 Methods for detecting neurodegenerative diseases or disorders |
06/07/2012 | CA2817919A1 Electrokinetic device for capturing assayable agents in a dielectric fluid |
06/07/2012 | CA2815400A1 Determination of sulphur dioxide in a liquid |
06/07/2012 | CA2813165A1 Detection of adenylate cyclase |
06/07/2012 | CA2757559A1 Method and apparatus for analyzing samples of metal melts |
06/06/2012 | EP2461163A2 Assays using surface-enhanced raman spectroscopy (sers)-active particles |
06/06/2012 | EP2461162A1 Method for determining the titre of viruses by using infectious standards |
06/06/2012 | EP2461161A1 Alloyed metal colloid |
06/06/2012 | EP2461160A1 System for analysing a bodily fluid sample |
06/06/2012 | EP2461159A1 Method of fabricating sensors having functionalized resonating beams |
06/06/2012 | EP2461156A1 Assay plates reader systems and methods for luminescence test measurements |
06/06/2012 | EP2460939A1 Determination of a waterway characteristic |
06/06/2012 | EP2460892A2 Method and kit for prognosis mantle cell lymphoma |
06/06/2012 | EP2460887A1 Microaggregates including endothelial cells |
06/06/2012 | EP2460886A1 Predicting treatment response in cancer subjects |
06/06/2012 | EP2460880A1 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells |
06/06/2012 | EP2460876A2 Method for identifying senescent mesenchymal stem cells |
06/06/2012 | EP2460830A2 IL-18 binding proteins |
06/06/2012 | EP2460829A2 IL-18 binding proteins |
06/06/2012 | EP2460822A2 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
06/06/2012 | EP2460542A1 Pancreatic endocrine cell indicator and utilization of same |
06/06/2012 | EP2460016A2 Genetically modified rat models for pharmacokinetics |
06/06/2012 | EP2460015A1 Use of mimecan in the assessment of heart failure |
06/06/2012 | EP2460014A1 Method for predicting the likelihood of an onset of an inflammation associated organ failure |
06/06/2012 | EP2460013A1 Folate-targeted diagnostics and treatment |
06/06/2012 | EP2460012A1 Method for detection of, or the risk of, bladder cancer |
06/06/2012 | EP2460011A2 Assay tools and methods of use |
06/06/2012 | EP2460010A1 Agonists and antagonists of human bitter taste receptor tas2r49 and uses thereof |
06/06/2012 | EP2460009A1 Device for detection of antigens and uses thereof |
06/06/2012 | EP2460008A2 Methods to characterize cell reprogramming and uses thereof |
06/06/2012 | EP2460007A1 Serum markers predicting clinical response to anti-tnfalpha antibodies in patients with psoriatic arthritis |
06/06/2012 | EP2460006A2 Methods and compositions for identifying and validating modulators of cell fate |
06/06/2012 | EP2460004A2 Phase behavior analysis using a microfluidic platform |
06/06/2012 | EP2460002A1 Method and apparatus for performing mass spectrometry |
06/06/2012 | EP2459999A1 Ultrasound assisted immunoassay |
06/06/2012 | EP2459981A1 Method for predicting a physical interaction effect between a tire and a surface course |
06/06/2012 | EP2459752A2 Enterococcus and fecal bacteroides for rapid water quality assessment |
06/06/2012 | EP2459751A1 Method for determining the presence and concentration of analytes using a nucleic acid ligand and rare earth element |
06/06/2012 | EP2459750A1 Method and apparatus for conducting an assay |
06/06/2012 | EP2459742A1 New diagnostic tools for alzheimer disease |
06/06/2012 | EP2459735A2 Novel peptidase substrates |
06/06/2012 | EP2459734A2 Novel peptidase substrates |
06/06/2012 | EP2459731A2 Pairing processes for preparing alloreactive cytotoxic t cells |
06/06/2012 | EP2459730A1 Improvements relating to sensor devices |
06/06/2012 | EP2459729A2 Dual variable domain immunoglobulins and uses thereof |
06/06/2012 | EP2459707A2 Compositions and methods of preparing alloreactive cytotoxic t cells |